Wockhardt (BOM:532300) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Wockhardt FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Wockhardt's Free Cash Flow for the three months ended in Dec. 2023 was ₹0 Mil. Wockhardt's Revenue for the three months ended in Dec. 2023 was ₹7,010 Mil. Therefore, Wockhardt's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Wockhardt's current FCF Yield % is -0.65%.

The historical rank and industry rank for Wockhardt's FCF Margin % or its related term are showing as below:

BOM:532300' s FCF Margin % Range Over the Past 10 Years
Min: -16.94 Med: -2.35 Max: 20.99
Current: -2.02

During the past 13 years, the highest FCF Margin % of Wockhardt was 20.99%. The lowest was -16.94%. And the median was -2.35%.

BOM:532300's FCF Margin % is ranked worse than
55.57% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 0.085 vs BOM:532300: -2.02

Wockhardt FCF Margin % Historical Data

The historical data trend for Wockhardt's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wockhardt FCF Margin % Chart

Wockhardt Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

-2.58

16.82

-16.78

6.26

-2.12

Wockhardt Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Wockhardt's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Wockhardt's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wockhardt's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wockhardt's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Wockhardt's FCF Margin % falls into.

Wockhardt FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Wockhardt's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	-560	/	26460
	=	-2.12 %

Wockhardt's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	7010
	=	0.00 %

Wockhardt FCF Margin % Related Terms

Thank you for viewing the detailed overview of Wockhardt's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Wockhardt (BOM:532300) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wockhardt Ltd (BOM:532300) » Definitions » FCF Margin %

Traded in Other Exchanges

WOCKPHARMA:India

Address

Wockhardt Towers, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051

Website

http://www.wockhardt.com

Wockhardt Ltd is a major drug manufacturing company with a focus on pharmaceutical and biotechnology products. The company conducts research in the fields of pharmaceuticals and biotechnology while also operating its chain of Super Specialty Hospitals. The vast majority of the company's revenue is generated in Europe. The company also operates in China, Japan, and Russia. The company's strategy includes the use of acquisitions, strategic partnerships, and contract manufacturing.

Wockhardt (BOM:532300) Headlines

No Headlines